<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03729453</url>
  </required_header>
  <id_info>
    <org_study_id>E7107</org_study_id>
    <nct_id>NCT03729453</nct_id>
  </id_info>
  <brief_title>Intra-operative Pancreatoscopy in Patients With IPMN</brief_title>
  <official_title>Intra-operative Pancreatoscopy in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To demonstrate the added value of intraoperative pancreatoscopy in patients undergoing
      partial pancreatic resection for the treatment of Intraductal Papillary Mucinous Neoplasm
      (IPMN) as it pertains to detection of discontinuous (skip) lesions in the remnant pancreas;
      to generate a hypothesis for a subsequent randomized control trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to demonstrate the added value of intraoperative
      pancreatoscopy in patients undergoing partial pancreatic resection for the treatment of
      Intraductal Papillary Mucinous Neoplasm (IPMN) as it pertains to detection of discontinuous
      (skip) lesions in the remnant pancreas. A secondary study objective is to generate a
      hypothesis for a subsequent randomized controlled trial comparing diagnostic accuracy of
      intra-operative pancreatoscopy and SpyBite™ with the diagnostic accuracy of intra-operative
      frozen section in patients undergoing resection
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 20, 2019</start_date>
  <completion_date type="Anticipated">March 2027</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of detection of discontinuous (skip) lesions along the main pancreatic duct</measure>
    <time_frame>During index procedure</time_frame>
    <description>Rate of detection of discontinuous (skip) lesions along the main pancreatic duct of patients with IPMN using intraoperative pancreatoscopy based on visual impression of IPMN and/or pancreatoscopy guided biopsies</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical success</measure>
    <time_frame>During index procedure</time_frame>
    <description>Ability to advance the pancreatoscope along the entire main pancreatic duct length or until clinically needed; to visualize the potential lesion(s); or to obtain a tissue sample with SpyBite where applicable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Event Evaluation</measure>
    <time_frame>Five years</time_frame>
    <description>Evaluate all serious adverse events related to the intraoperative pancreatoscopy procedure and/or device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence</measure>
    <time_frame>Five years</time_frame>
    <description>Recurrence of IPMN within 5 years post-surgery evaluated with regular MRI or alternative radiological method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of visual and biopsy diagnosis</measure>
    <time_frame>During index procedure</time_frame>
    <description>Comparison based on exploration with Spy Glass of the resected specimen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inter-observer correspondence of visual impression of IPMN</measure>
    <time_frame>During index procedure</time_frame>
    <description>Based on intra-operative impression and on review of recorded pancreatoscopy images/videos</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Intraductal Papillary Mucinous Neoplasm</condition>
  <arm_group>
    <arm_group_label>Intraoperative Pancreatoscopy</arm_group_label>
    <description>All subjects will undergo the intraoperative pancreatoscopy with SpyGlass procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SpyGlass</intervention_name>
    <description>Visualization of main pancreatic duct with SpyGlass catheter.</description>
    <arm_group_label>Intraoperative Pancreatoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for surgery for suspected MD-IPMN or Mixed IPMN resection.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient scheduled for surgery for suspected MD-IPMN or Mixed IPMN within 4-6 weeks of
             enrollment

          2. Diameter of pancreatic main duct &gt;5mm on pre-operative MRI or CT

          3. Written informed consent from patient to participate in the study, including
             compliance with study procedures

        Exclusion Criteria:

          1. Contraindication for pancreatoscopy

          2. Age: less than 18 years

          3. Pregnant women, evaluated per local clinical standard
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco Del Chiaro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_official>
    <last_name>G.V. Rao, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asian Institute of Gastroenterology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jun Yu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc Besselink, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yi Miao, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nanjing Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sohei Satoi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kansai Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Urban Arnelo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Umeå</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christian Schmidt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Danielle Vannan</last_name>
    <phone>508-683-4139</phone>
    <email>Danielle.Vannan@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Srey Yin</last_name>
    <phone>508-683-4162</phone>
    <email>Srey.Yin@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Richard Schulick, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Indiana University Health</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christian Schmidt, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Hospital University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jun Yu, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yi Miao, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asian Institute of Gastroenterology</name>
      <address>
        <city>Hyderabad</city>
        <zip>500-082</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>G.V. Rao, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kansai Medical University</name>
      <address>
        <city>Hirakata City</city>
        <state>Osaka</state>
        <zip>573-1010</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sohei Satoi, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marc Besselink, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of UMEA</name>
      <address>
        <city>Umea</city>
        <zip>907 37</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Urban Arnelo, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
    <country>India</country>
    <country>Japan</country>
    <country>Netherlands</country>
    <country>Sweden</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>November 1, 2018</study_first_submitted>
  <study_first_submitted_qc>November 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2018</study_first_posted>
  <last_update_submitted>June 23, 2020</last_update_submitted>
  <last_update_submitted_qc>June 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IPMN</keyword>
  <keyword>SpyGlass</keyword>
  <keyword>Pancreatoscopy</keyword>
  <keyword>Intraductal Papillary Mucinous Neoplasm</keyword>
  <keyword>Intraoperative</keyword>
  <keyword>Surgical</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

